Balance Sheet Components - Components of Accrued Liabilities (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Balance Sheet Related Disclosures [Abstract] | ||
| Accrued issuance costs | $ 1,881 | |
| Accrued manufacturing and clinical expenses | 541 | $ 1,016 |
| Accrued compensation | 1,551 | 947 |
| Accrued legal and professional fees | 97 | 276 |
| Accrued other expenses | 132 | 3 |
| Total Accrued Liabilities | $ 4,202 | $ 2,242 |
| X | ||||||||||
- Definition Accrued compensation. No definition available.
|
| X | ||||||||||
- Definition Accrued issuance costs. No definition available.
|
| X | ||||||||||
- Definition Accrued manufacturing and clinical expenses. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|